.
New Delhi, April 26 (MondayMirror.com) The Drugs Controller General of India (DCGI) on Tuesday approved the restricted emergency use authorisation (EUA) to Bharat Biotech’s Covaxin for children between the age of 6-12 years, sources said.
The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event with due analysis every 15 days for the first two months and monthly thereafter upto 5 months, said the source familiar with the development.
This development comes after the Subject Expert Committee (SEC) discussed recommendations for the restricted emergency use of Covaxin in children aged between 2-12 years.
However, the SEC, after a meeting on Thursday, had recommended restricted emergency use of Biological E’s Covid-19 vaccine, Corbevax, in children aged 5-12 years.
Source: IANS
In a cinematic era dominated by high-speed action and multiverse fantasies, Ek Deewane Ki Deewaniyat…
Bollywood superstar Shah Rukh Khan opened up about Kajol going the extra mile to recreate…
Actress Priyamani opened up about her experience working with veteran actor Manoj Bajpayee on the…
Former Bigg Boss winner Gauahar Khan has been actively voicing her views on the ongoing…
Randeep Hooda and his wife Lin Laishram shared a glimpse from their Karva Chauth celebrations…
Actress Shagun Sharma, who plays Paridhi in "Kyunki Saas Bhi Kabhi Bahu Thi Season 2",…